Bluejay Diagnostics, Inc. BJDX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 911.30K | 1.13M | 875.60K | 831.30K | 1.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.35M | 1.94M | 1.43M | 1.62M | 1.99M |
| Operating Income | -2.35M | -1.94M | -1.43M | -1.62M | -1.99M |
| Income Before Tax | -2.32M | -1.92M | -1.43M | -1.60M | -1.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.32M | -1.92M | -1.43M | -1.60M | -1.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.32M | -1.92M | -1.43M | -1.60M | -1.96M |
| EBIT | -2.35M | -1.94M | -1.43M | -1.62M | -1.99M |
| EBITDA | -2.32M | -1.91M | -1.40M | -1.61M | -1.97M |
| EPS Basic | -4.47 | -7.80 | -6.24 | -16.23 | -22.57 |
| Normalized Basic EPS | -2.79 | -4.87 | -3.80 | -10.15 | -14.11 |
| EPS Diluted | -4.47 | -7.80 | -6.24 | -16.23 | -22.57 |
| Normalized Diluted EPS | -2.79 | -4.87 | -3.80 | -10.15 | -14.11 |
| Average Basic Shares Outstanding | 519.80K | 246.20K | 229.30K | 98.40K | 86.70K |
| Average Diluted Shares Outstanding | 519.80K | 246.20K | 229.30K | 98.40K | 86.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |